Vorinostat [vorinostat]
topical
5
- Terms
-
SAHA
suberoylanilid hydroxamová kyselina
Zolinza
-
18F-SAHA
18F-Suberoylanilide Hydroxamic Acid
M344
MK-0683
MK0683
N-Hydroxy-N'-phenyloctanediamide
N1-Hydroxy-N8-phenyloctanediamide
NHNPODA
Suberanilohydroxamic Acid
Suberoyl Anilide Hydroxamic Acid
Suberoylanilide Hydroxamic Acid
Zolinza
Persistent link
https://www.medvik.cz/link/D000077337
Definition
A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
- DUI
- D000077337 MeSH Browser
- CUI
- M0288128
- RN
- 58IFB293JI
- History note
- 2019 (1998)
- Public note
- 2019; VORINOSTAT was indexed under HYDROXAMIC ACIDS 1998-2018
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 1
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 2
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records